Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules.

Rapoport BL, Steel HC, Hlatshwayo N, Theron AJ, Meyer PWA, [...]

By |2023-04-13T10:41:59+02:00April 13, 2023|2022: April to June|Comments Off on Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules.
Go to Top